Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation ; volume:9 ; number:3 ; year:2019 ; pages:149-157
Case reports in nephrology and dialysis ; 9, Heft 3 (2019), 149-157
- Urheber
-
Spica, Davide
Junker, Till
Dickenmann, Michael
Schaub, Stefan
Steiger, Jürg
Rüfli, Tanja
Halter, Jörg
Hopfer, Helmut
Holbro, Andreas
Hirt-Minkowski, Patricia
- DOI
-
10.1159/000503951
- URN
-
urn:nbn:de:101:1-2020011600391032517426
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spica, Davide
- Junker, Till
- Dickenmann, Michael
- Schaub, Stefan
- Steiger, Jürg
- Rüfli, Tanja
- Halter, Jörg
- Hopfer, Helmut
- Holbro, Andreas
- Hirt-Minkowski, Patricia
Ähnliche Objekte (12)
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Daratumumab
Pilot Experience with ABO-Incompatible Kidney Transplantation as a Second Transplant
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation
Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
Successful ABO and HLA incompatible kidney transplantation in children in the UK
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Daratumumab
Pilot Experience with ABO-Incompatible Kidney Transplantation as a Second Transplant
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation
Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
Successful ABO and HLA incompatible kidney transplantation in children in the UK
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Daratumumab
Pilot Experience with ABO-Incompatible Kidney Transplantation as a Second Transplant
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation
Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
Successful ABO and HLA incompatible kidney transplantation in children in the UK